UBS analyst A.J. Rice maintains Universal Health Servs (NYSE:UHS) with a Buy and raises the price target from $247 to $267.
UBS Maintains Buy on Universal Health Servs, Raises Price Target to $267
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.